Search Results - "Olariu, Andrea"

Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use by Creinin, Mitchell D., Schreiber, Courtney A., Turok, David K., Cwiak, Carrie, Chen, Beatrice A., Olariu, Andrea I.

“…Extending hormonal intrauterine system duration will allow users to have less need for procedures to provide long-term contraception. This study aimed to…”
Get full text

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System by Teal, Stephanie B., Turok, David K., Chen, Beatrice A., Kimble, Thomas, Olariu, Andrea I., Creinin, Mitchell D.

“…OBJECTIVE:To assess the 5-year contraceptive efficacy and safety of a levonorgestrel (LNG) 52-mg intrauterine system (IUS) from an ongoing 10-year phase 3…”
Get full text

Corrigendum to ‘Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use’ [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871.e7] by Creinin, Mitchell D., Schreiber, Courtney A., Turok, David K., Cwiak, Carrie, Chen, Beatrice A., Olariu, Andrea I.

Get full text

Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use by Chen, Beatrice A., Kimble, Thomas, Harris, Lisa H., Kerns, Jennifer L., Olariu, Andrea I., Creinin, Mitchell D.

“…Medicines360. The Sponsor, Medicines360, designed the study and oversaw its conduct, including funding the trial and providing all study product free of charge…”
Get full text

Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding by Chen, Beatrice A., Eisenberg, David L., Schreiber, Courtney A., Turok, David K., Olariu, Andrea I., Creinin, Mitchell D.

“…The levonorgestrel 52-mg intrauterine system has proven efficacy for heavy menstrual bleeding treatment in clinical trials, but few data exist to demonstrate…”
Get full text

Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system by Westhoff, Carolyn L., Keder, Lisa M., Gangestad, Angelina, Teal, Stephanie B., Olariu, Andrea I., Creinin, Mitchell D.

“…To assess 6-year contraceptive efficacy and safety of a levonorgestrel 52 mg intrauterine system (IUS). We assessed pregnancy rates through 72 months in women…”
Get full text

The Levonorgestrel 52 mg Intrauterine System Is Effective and Safe for Six Years [13M] by Westhoff, Carolyn L, Keder, Lisa M, Gangestad, Angelina K, Teal, Stephanie Beth, Olariu, Andrea I, Creinin, Mitchell D

“…INTRODUCTION:Liletta®, a levonorgestrel (LNG) 52mg contraceptive intrauterine system (IUS), is under investigation in an ongoing multicenter trial for up to…”
Get full text

Feasibility study of a single‐handed inserter for levonorgestrel 52 mg intrauterine device placement by Eisenberg, David L., Schreiber, Courtney A., Blumenthal, Paul D., Turok, David K., Olariu, Andrea I., Creinin, Mitchell D.

“…Objective To assess placement outcomes using a levonorgestrel 52 mg intrauterine device (IUD) inserter designed for single‐handed use. Methods Investigators…”
Get full text

Bleeding patterns for the Liletta® levonorgestrel 52 mg intrauterine system by Schreiber, Courtney A., Teal, Stephanie B., Blumenthal, Paul D., Keder, Lisa M., Olariu, Andrea I., Creinin, Mitchell D.

“…Purpose: Evaluate bleeding patterns for the Liletta ® levonorgestrel 52 mg intrauterine system (IUS) using the World Health Organization Belsey definitions…”
Get full text

First-Year Side Effect Rates in Nulliparous and Parous Levonorgestrel 52 mg Intrauterine System Users [12J] by Cwiak, Carrie, Blumenthal, Paul D., Kerns, Jennifer, Westhoff, Carolyn, Olariu, Andrea I., Creinin, Mitchell D.

“…INTRODUCTION: We investigated the impact of parity on side effects during the first year after levonorgestrel 52 mg intrauterine system (IUS) placement…”
Get full text

LEVONORGESTREL 52 MG INTRAUTERINE SYSTEM EFFICACY AND SAFETY THROUGH 8 YEARS OF USE by Creinin, Mitchell D., Schreiber, Courtney A., Turok, David K., Cwiak, Carrie, Chen, Beatrice A., Olariu, Andrea I.

Get full text

Levonorgestrel 52 mg Intrauterine System Efficacy and Safety Through 8 Years of Use by Creinin, Mitchell D., Schreiber, Courtney A., Turok, David K., Cwiak, Carrie, Chen, Beatrice A., Olariu, Andrea I.

“…(Abstracted from Am J Obstet Gynecol 2022; doi10.1016/j.ajog.2022.05.022) Over the past several years, the longevity of use for long-acting reversible…”
Get full text

BLEEDING PATTERNS FROM MONTHS 60 TO 72 WITH USE OF A LEVONORGESTREL 52 MG INTRAUTERINE SYSTEM by Jensen, Jeffrey T., Carr, Bruce R., Kimble, Thomas D., Thomas, Michael A., Olariu, Andrea I., Creinin, Mitchell D.

Get full text

Levonorgestrel release rates over 5 years with the Liletta® 52-mg intrauterine system by Creinin, Mitchell D, Jansen, Rolf, Starr, Robert M, Gobburu, Joga, Gopalakrishnan, Mathangi, Olariu, Andrea

“…Abstract Objective To understand the potential duration of action for Liletta®, we conducted this study to estimate levonorgestrel (LNG) release rates over…”
Get full text

Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta®) discontinuation by Carr, Bruce R., Thomas, Michael A., Gangestad, Angelina, Eisenberg, David L., Olariu, Andrea, Creinin, Mitchell D.

“…Evaluate reproductive function in nulligravid and gravid women after levonorgestrel 52 mg intrauterine system (IUS) discontinuation based on time to pregnancy…”
Get full text

Pre-removal plasma levonorgestrel level and return ot fertility after levonorgestrel 52 mg intrauterine system discontinuation by Thomas, Michael A., Stuart, Gretchen S., Westhoff, Carolyn L., Eisenberg, David L., Olariu, Andrea I., Creinin, Mitchell D.

Get full text

Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years by Gilliam, Melissa L., Jensen, Jeffrey T., Eisenberg, David L., Thomas, Michael A., Olariu, Andrea, Creinin, Mitchell D.

“…Assess the relationship between parity and prior route of delivery to levonorgestrel 52 mg intrauterine system (IUS) expulsion during the first 72 months of…”
Get full text

Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use by Darney, Philip D., Stuart, Gretchen S., Thomas, Michael A., Cwiak, Carrie, Olariu, Andrea, Creinin, Mitchell D.

“…The objective was to evaluate amenorrhea patterns and predictors of amenorrhea during the first year after levonorgestrel 52 mg intrauterine system (IUS)…”
Get full text